Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
Ashraf M El-BatarnyAssistant Professor of Ophthalmology, Tanta University, Egypt; Chief of Vitreoretinal Service, Magrabi Eye and Ear Hospital, Muscat, Sultanate of OmanPurpose: To evaluate the effect of intravitreal injection of Avastin, bevacizumab (IVA) on diabetic vitrectomy and on the postopera...
Main Author: | Ashraf M El-Batarny |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-02-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/intravitreal-bevacizumab-as-an-adjunctive-therapy-before-diabetic-vitr-a2854 |
Similar Items
-
Use of intravitreal bevacizumab or triamcinolone acetonide as a preoperative adjunct to vitrectomy for vitreous haemorrhage in diabetics
by: Daniel Araújo Ferraz, et al.
Published: (2013-02-01) -
Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
by: Mehmet Demir, et al.
Published: (2013-07-01) -
Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
by: Mehmet Demir, et al.
Published: (2013-01-01) -
Effect of Ranibizumab intravitreal injection as an adjunct before vitrectomy surgery in the treatment of patients with proliferative diabetic retinopathy
by: Yang Zhang, et al.
Published: (2015-08-01) -
Does preoperative intravitreal bevacizumab reduce complications of vitrectomy for proliferative diabetic retinopathy?
by: Daniela Véliz, et al.
Published: (2014-12-01)